在创伤性脑损伤中验证韩国摩斯注意力评分尺度:可靠性和有效性
Sung Hoon Jeong1,2,3, Jun Hee Won2,4, Byung-Mo Oh5,6,7
1Department of Health Policy & Management, Inje University, Gimhae, Korea.
Korean journal of neurotrauma
|February 9, 2026
概括
韩国摩斯注意力评分尺度 (K-MARS) 是评估韩国中度至严重创伤性脑损伤 (msTBI) 患者注意力缺陷的可靠工具. 这种经过验证的尺度有助于制定个性化的认知康复计划.
科学领域:
- 神经科学是一个神经科学.
- 心理测量 心理测量 心理测量
- 康复医学 康复医学 康复医学
背景情况:
- 创伤性脑损伤 (TBI) 经常导致注意力缺陷,影响患者的康复和生活质量.
- 准确评估注意力对于有效的认知康复策略至关重要.
- 现有的注意力评估工具可能无法在韩国人群的文化上进行调整或验证.
研究的目的:
- 将莫斯注意力评分表 (MARS) 翻译成韩语.
- 验证韩国版本 (K-MARS) 的心理测量特性,用于韩国中度至重度TBI (msTBI) 的住院患者.
主要方法:
- 一项前性,单中心研究,涉及51名msTBI住院患者.
- 标准化跨文化适应K-MARS翻译.
- 使用认知评估评估内部一致性,测试-重新测试可靠性和融合有效性.
主要成果:
- K-MARS显示出强大的内部一致性 (克朗巴赫的α=0.870).
- 证实了优异的测试重复测试可靠性 (总分数和子尺度的ICC>0.90).
- 在K-MARS得分和认知性能指标之间显著的相关性表明了良好的融合有效性.
结论:
- 该K-MARS是一个心理测量声音和有效的仪器,用于评估韩国MSTBI患者的注意力.
- 该工具有助于识别注意力缺陷,并提供量身定制的认知康复.
- K-MARS支持TBI幸存者的注意力相关行为评估中的临床决策.
相关概念视频
Reliability and Validity
14.1K
Reliability and validity are two important considerations that must be made with any type of data collection. Reliability refers to the ability to consistently produce a given result. In the context of psychological research, this would mean that any instruments or tools used to collect data do so in consistent, reproducible ways.
14.1K
Data Validation
2.1K
Method validation is a crucial process in analytical chemistry designed to confirm that a given method consistently produces reliable and high-quality results. This process is essential when a method is applied to different sample matrices or when procedural modifications are made, ensuring that the results meet acceptable standards across various applications.
Key parameters for method validation include:
Key parameters for method validation include:
2.1K
Data Validation
6.9K
Data validation is an essential part of a comprehensive assessment. Validation is confirming or verifying and opening the door to gathering more assessment data as it clarifies vague or unclear data. The process of checking and verifying the collected information is called data validation. The primary purpose of data validation is to ensure data is as free from error, bias, and misinterpretation as possible.
Nursing assessment guides are generally based on holistic models rather than medical...
Nursing assessment guides are generally based on holistic models rather than medical...
6.9K
Formulating and Validating Nursing Diagnosis I
4.0K
A nursing diagnosis is written when the nurse recognizes a cluster of essential patient data indicating health problems treated with independent nursing interventions. The standardized terminologies of a nursing diagnosis help nurses identify and treat patients' problems. Every electronic health record that uses nursing diagnosis must employ standard diagnostic terminology. Developing an efficient, individualized care plan begins with accurate nursing diagnoses.
There are thirteen domains...
There are thirteen domains...
4.0K
Formulating and Validating Nursing Diagnosis II
4.0K
Nursing diagnoses represent a problem validated by major defining characteristics. There are four categories of nursing diagnoses: problem-focused, risk, health promotion or wellness, and syndrome. The anatomy of a nursing diagnosis includes three components: problem statement or diagnostic label, defining characteristics, and related factors.
Risk nursing diagnoses represent clinical judgments of an individual, family, or community more vulnerable to developing the health problem than others...
Risk nursing diagnoses represent clinical judgments of an individual, family, or community more vulnerable to developing the health problem than others...
4.0K
In Vitro Drug Release Testing: Overview, Development and Validation
363
In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
363


